Cancer Research Communications

Scope & Guideline

Innovating cancer treatment through shared insights.

Introduction

Explore the comprehensive scope of Cancer Research Communications through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Cancer Research Communications in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherAMER ASSOC CANCER RESEARCH
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCANCER RES COMMUN / Cancer Res. Commun.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404

Aims and Scopes

Cancer Research Communications aims to advance knowledge in the field of oncology through cutting-edge research and clinical studies. The journal encompasses a wide array of topics related to cancer biology, therapy, and patient outcomes, focusing on innovative approaches and methodologies.
  1. Cancer Therapeutics and Targeted Treatments:
    The journal regularly publishes studies on novel therapeutic agents, including targeted therapies, immunotherapies, and combination treatments. This includes exploration of drug mechanisms, resistance, and patient stratification based on genetic and molecular profiles.
  2. Cancer Biology and Mechanisms of Tumorigenesis:
    Research articles delve into the fundamental biological processes underlying cancer development and progression. This includes studies on genetic mutations, signaling pathways, and tumor microenvironment interactions that contribute to malignancy.
  3. Clinical Trials and Translational Research:
    A significant focus is placed on clinical studies, including phase I-III trials, that evaluate the safety and efficacy of new cancer treatments. This also includes studies on biomarkers and patient outcomes to inform clinical decision-making.
  4. Molecular and Cellular Oncology:
    The journal features research on cellular mechanisms, including the role of cancer stem cells, immune evasion, and the tumor microenvironment, emphasizing the molecular pathways that contribute to cancer progression.
  5. Cancer Epidemiology and Health Disparities:
    Research addressing disparities in cancer incidence, treatment outcomes, and access to care for various populations is a consistent theme. This includes studies that investigate the impact of socioeconomic factors on cancer risk and treatment.
Recent publications in Cancer Research Communications highlight several trending and emerging themes that demonstrate the journal's responsiveness to the evolving landscape of cancer research. These themes indicate where the field is heading and the innovative approaches being taken.
  1. Immunotherapy and Immune Microenvironment Studies:
    There is a significant increase in research focused on immunotherapy, including CAR T-cell therapies and immune checkpoint inhibitors. Studies exploring the immune microenvironment and its role in therapy response are gaining prominence, reflecting the growing importance of immuno-oncology.
  2. Precision Medicine and Biomarker Research:
    Publications increasingly emphasize the role of precision medicine, with a focus on identifying biomarkers for patient stratification and treatment efficacy. This trend aligns with the need for personalized treatment approaches tailored to individual patient profiles.
  3. Multi-Omics Approaches:
    Emerging research utilizing multi-omics strategies, such as genomics, proteomics, and metabolomics, is becoming more prevalent. These approaches aim to provide a comprehensive understanding of cancer biology and treatment responses.
  4. Targeting the Tumor Microenvironment:
    Studies investigating the tumor microenvironment's role in cancer progression and therapy resistance are on the rise. This includes research on stromal interactions, immune cell infiltration, and metabolic reprogramming within tumors.
  5. Health Disparities and Cancer Epidemiology:
    There is a growing focus on understanding health disparities in cancer outcomes, with research highlighting the influence of socioeconomic, racial, and geographic factors on cancer incidence and treatment access. This trend reflects a broader commitment to addressing inequities in cancer care.

Declining or Waning

While Cancer Research Communications continues to explore a vast array of cancer-related topics, certain themes appear to be declining in frequency or prominence. These waning scopes may reflect shifts in research focus or emerging priorities in the field.
  1. Traditional Chemotherapy Studies:
    There has been a noticeable decrease in studies focused solely on traditional chemotherapy regimens, as research increasingly shifts towards personalized medicine and targeted therapies that offer improved specificity and reduced toxicity.
  2. Basic Laboratory Techniques without Clinical Relevance:
    Research papers that focus exclusively on basic laboratory techniques or models, without a clear translational application or clinical relevance, appear to be less frequently published, as the journal emphasizes studies with direct implications for patient care.
  3. Single-Factor Studies:
    There is a waning interest in studies that investigate single factors in isolation, such as individual genetic mutations or isolated biochemical pathways, as the field moves towards integrative approaches that consider the multifactorial nature of cancer.
  4. General Cancer Awareness Campaigns:
    Papers focused on general cancer awareness and education initiatives without substantial data or research backing are becoming less prevalent, reflecting a trend towards more evidence-based, impactful research.

Similar Journals

CANCER SCIENCE

Unlocking the mysteries of cancer through rigorous research.
Publisher: WILEYISSN: 1347-9032Frequency: 12 issues/year

Cancer Science, an esteemed journal published by Wiley, stands at the forefront of oncology research, boasting an impressive impact factor and a classification in the Q1 category for its contributions in Cancer Research, Medicine, and Oncology as of 2023. Since its inception in 2003 and transitioning to an Open Access model in 2014, the journal has facilitated global dissemination of critical research findings, ensuring that vital information remains accessible to researchers, clinicians, and students alike. With its comprehensive scope covering cutting-edge discoveries in cancer biochemistry, genetics, and molecular biology, Cancer Science is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of cancer. The journal, located at 111 River St, Hoboken, NJ, is an essential resource for anyone dedicated to improving treatment outcomes and pushing the boundaries of cancer research.

Wspolczesna Onkologia-Contemporary Oncology

Elevating Standards in Cancer Research and Treatment
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1428-2526Frequency: 4 issues/year

Wspolczesna Onkologia - Contemporary Oncology is a leading open-access journal dedicated to the field of oncology and radiology, published by TERMEDIA PUBLISHING HOUSE LTD since 1999. With its ISSN 1428-2526 and E-ISSN 1897-4309, the journal has established a prominent place in scholarly publishing, contributing significantly to the advancement of cancer research and treatment modalities. Located in Poznań, Poland, it operates within a framework of high academic standards, currently holding a Q3 quartile ranking in Oncology and Q2 in Radiology, Nuclear Medicine, and Imaging for the year 2023. The journal serves as a valuable resource for researchers, medical professionals, and students alike, providing a platform for innovative studies and reviews that drive the clinical application of oncological practices. With its commitment to open access, Wspolczesna Onkologia allows for widespread dissemination of knowledge, ensuring that cutting-edge research is accessible to a global audience, thus bridging gaps in cancer care and fostering collaborative advancements in the field.

Cancer Drug Resistance

Unraveling the Mysteries of Drug Resistance in Cancer.
Publisher: OAE PUBLISHING INCISSN: Frequency: 1 issue/year

Cancer Drug Resistance is a premier journal published by OAE PUBLISHING INC, focusing on the critical field of oncology and pharmacology. Since its inception in 2018, the journal has been at the forefront of presenting innovative research aimed at understanding and overcoming drug resistance in cancer therapy. With an impressive impact factor reflected in its Q2 ranking in Cancer Research and a Q1 ranking in Pharmacology (medical) for 2023, Cancer Drug Resistance serves as a vital resource for researchers, clinicians, and students who are dedicated to advancing cancer treatment and improving patient outcomes. The journal's commitment to disseminating high-quality, peer-reviewed articles underscores its importance within the academic and medical communities. While it operates on an open-access model, facilitating widespread distribution and access to crucial research findings, the journal continuously strives to foster dialogue and collaboration among stakeholders in cancer research and pharmacology. Its mission is clear: to shine a light on the evolving challenges and breakthroughs in drug resistance, paving the way for enhanced therapeutic strategies and clinical solutions.

Molecular Cancer

Pioneering open access to vital cancer insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Cancer, published by BMC, stands as a premier open access journal dedicated to advancing our understanding of cancer biology, treatment, and prevention since its inception in 2002. With an impressive Q1 ranking in the domains of Cancer Research, Molecular Medicine, and Oncology, this journal occupies a significant position in the academic landscape, emphasizing high-quality research that influences clinical practices and future studies. The journal is indexed in leading databases with exceptional Scopus ranks, reflecting its rigorous peer-review process and impactful contributions to the field, where it ranks in the top 2-3 positions across various relevant categories. Based in the United Kingdom, Molecular Cancer offers researchers worldwide a valuable platform for disseminating innovative findings that drive the biomedical community forward. The journal's open access model ensures that groundbreaking research is freely accessible, fostering collaboration and knowledge sharing among professionals, students, and academics alike. Explore cutting-edge developments in cancer research through Molecular Cancer and join a community committed to improving patient outcomes and advancing scientific discovery.

Cancer Communications

Connecting Researchers, Practitioners, and Patients in Oncology
Publisher: WILEYISSN: Frequency: 12 issues/year

Cancer Communications, published by WILEY, is a leading open-access journal that has positioned itself at the forefront of cancer research and oncology since its inception in 2017. With an impressive HIndex reflective of its scholarly impact and recognized in the Q1 category for both Cancer Research and Oncology as of 2023, this journal consistently ranks in the top echelons of its field, specifically at Rank #16/404 and Rank #13/230 in their respective categories on Scopus. Cancer Communications aims to disseminate cutting-edge research findings, innovative methodologies, and significant advancements in cancer treatments, thereby fostering a deeper understanding of oncology among researchers, healthcare professionals, and students. The journal operates under an Open Access model since 2018, ensuring that vital research is accessible to a global audience, thus enhancing collaboration and knowledge sharing necessary to tackle one of the most pressing health challenges of our time. Located in Hoboken, NJ, United States, and with a strong commitment to scientific excellence, Cancer Communications remains an essential resource for anyone engaged in the fight against cancer.

NATURE REVIEWS CANCER

Discovering Breakthroughs in Cancer Biology and Treatment
Publisher: NATURE PORTFOLIOISSN: 1474-175XFrequency: 12 issues/year

NATURE REVIEWS CANCER, a premier journal published by NATURE PORTFOLIO, stands as a cornerstone in the field of oncology, focusing on delivering high-quality, comprehensive reviews that shape our understanding of cancer biology, prevention, and treatment. With an impressive impact in the academic community, it ranks Q1 in both Cancer Research and Oncology categories as of 2023, further denoted by a remarkable Scopus ranking as the top journal in Cancer Research and second in Oncology. This ensures that published articles not only set the standard for scientific excellence but also drive significant advancements in cancer research methodologies and practices. The journal's targeted audience, including researchers, practitioners, and students, will greatly benefit from its insightful analyses and interdisciplinary approach. While it operates under a traditional subscription model, the rich content and vast expertise presented in its articles foster a global dialogue on cancer-related issues, making it an essential resource for anyone dedicated to the advancement of cancer science.

CANCER INVESTIGATION

Unraveling the complexities of cancer through rigorous inquiry.
Publisher: TAYLOR & FRANCIS INCISSN: 0735-7907Frequency: 10 issues/year

CANCER INVESTIGATION is a distinguished peer-reviewed journal published by Taylor & Francis Inc, dedicated to the advancing field of cancer research and oncology. With an ISSN of 0735-7907 and E-ISSN of 1532-4192, this journal has been a pivotal resource for professionals and researchers since its inception in 1983, continually contributing to the evolving landscape of cancer investigation until its convergence in 2024. CANCER INVESTIGATION boasts noteworthy rankings in 2023, including Q3 in Cancer Research and Q2 in Medicine (miscellaneous), highlighting its relevance and impact in these critical areas. The journal's commitment to disseminating innovative research and comprehensive reviews makes it an essential platform for those engaged in cancer studies and related disciplines. While currently not available as an open-access publication, CANCER INVESTIGATION remains an invaluable tool for understanding the complexities of cancer, offering insights that drive scientific advancements and improve patient outcomes.

Chinese Journal of Cancer Research

Pioneering insights into cancer biology and treatment.
Publisher: CHINESE JOURNAL CANCER RESEARCH COISSN: 1000-9604Frequency: 4 issues/year

Chinese Journal of Cancer Research, published by Chinese Journal Cancer Research Co, is a pivotal platform for disseminating significant findings in the field of oncology. Since its inception in 1988, the journal has provided a comprehensive forum for cancer research, featuring peer-reviewed articles that cover various aspects of cancer biology, prevention, diagnosis, and treatment. Although the journal's coverage is currently discontinued in Scopus and holds an HIndex that has not been specified, it is ranked in the 65th percentile in Medicine - Oncology and the 48th percentile in Biochemistry, Genetics and Molecular Biology - Cancer Research. This reflects its commitment to maintaining quality and relevance in the rapidly evolving field of cancer research. Researchers, professionals, and students are encouraged to explore its rich archive of studies and breakthroughs to enhance their understanding and further their research. For access, the publication remains instrumental for those invested in advancing the global fight against cancer.

Annual Review of Cancer Biology

Charting New Directions in Cancer Studies
Publisher: ANNUAL REVIEWSISSN: 2472-3428Frequency: 1 issue/year

Annual Review of Cancer Biology is a pivotal journal published by Annual Reviews, specializing in the rapidly evolving field of cancer research. With an impact factor positioned in the distinguished Q1 quartile of Cancer Research, Cell Biology, and Oncology categories, this journal ensures that it showcases the highest quality of scholarly contributions. Indexed in Scopus, it ranks among the top in its fields, reflecting its strong influence and relevance, with remarkable percentiles indicating its esteemed position within the research community. Although not an open-access journal, it provides a comprehensive platform for advancing the frontiers of cancer biology through rigorously curated reviews, highlighting key developments, breakthroughs, and future directions that inform both academia and clinical applications. As a valuable resource for researchers, professionals, and students, the Annual Review of Cancer Biology serves as an essential guide for understanding and addressing the complexities of cancer biology today.

CANCER IMMUNOLOGY IMMUNOTHERAPY

Fostering Breakthroughs in Cancer Treatment Strategies
Publisher: SPRINGERISSN: 0340-7004Frequency: 12 issues/year

Cancer Immunology Immunotherapy, published by Springer, stands as a premier journal in the fields of cancer research and immunology, holding a prestigious Q1 ranking across multiple categories, including Oncology and Medicine as of 2023. With an ISSN of 0340-7004 and an E-ISSN of 1432-0851, this journal has been a pivotal platform for groundbreaking research since its inception in 1976, continuing to provide insight into the complex interactions between the immune system and cancer. The journal's scope encompasses a wide array of topics, including novel therapeutic strategies, immunological mechanisms, and translational science aimed at advancing treatment outcomes for cancer patients. Renowned for its rigorous peer-review process and high impact factor, it attracts contributions from leading experts and researchers around the globe, positioning itself among the top-tier publications with Scopus rankings that reflect its vital role in advancing the field. Access options are generally subscription-based, ensuring a comprehensive resource for professionals and academics seeking to deepen their understanding and make meaningful contributions to cancer immunotherapy.